Skip to main content

Children's Health & Discovery Initiative Seminar Series

Thursday, June 28, 2018
P. Brian Smith

The goal of the Children’s Health & Discovery Initiative (CHDI) is to foster multidisciplinary and innovative research that will positively impact childhood and lifelong health. Efforts in four key research focus areas (genes and biology, physical environment, social and economic factors, and health and behavior needs) will inform prevention, risk screening, and treatment, as well as provide training opportunities for the next generation of pediatrician-scientists to learn from Duke’s cadre of experts. As part of our goal of fostering multidisciplinary collaborations, the CHDI is holding seminar/brainstorming sessions, which we’ve termed “Great Minds Think for Kids”. These sessions will include a 40-minute research-in-progress talk from a guest speaker, followed by a 40-minute brainstorming/group discussion session led by the guest speaker and a member of the CHDI scientific leadership.

Details about the July seminar/brainstorming session follow:

Date: July 16, 2018
Time: 8:30 am to 10:00 am
Location: Trent Semans Center, Room 3075 (Conference Room 3)

Seminar Title: "Environmental influences on Child Health Outcomes (ECHO): Current Status of the ECHO-wide Cohort Data Collection Protocol”
Speaker: P. Brian Smith, MD, MHS, MPH
Samuel L. Katz Distinguished Professor of Pediatrics
Division of Neonatology; Chief, Division of Quantitative Sciences
Member, Duke Clinical Research Institute
Duke University School of Medicine

Brian Smith, MD, MHS, MPH, is the Samuel L. Katz Distinguished Professor of Pediatrics in the Division of Neonatology, Chief of the Division of Quantitative Sciences, and a member of the Duke Clinical Research Institute. His research focuses on the breaking down of barriers to appropriate drug dosing and safety studies in infants and children, especially low birth weight and premature infants. He has focused on optimizing clinical trial design methods to determine the dosing, safety, and efficacy of therapeutic agents used in infants—neonatal clinical pharmacology. Dr. Smith is a recognized leader in the implementation of networks dedicated to child health and is the principal investigator for the Environmental influences on Child Health Outcomes (ECHO) Coordinating Center. He earned his medical degree from Mercer University and completed his residency in pediatrics and a fellowship in neonatal medicine at Duke in 2004 and 2007, respectively. He completed an MHS in clinical research from Duke University in 2006 and an MPH in biostatistics from the University of North Carolina at Chapel Hill in 2009.